2BB score and signals
Aardvark Therapeutics, Inc.’s current 2BB score is 20 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 39 | Weakening |
| Financial strength | 26 | Weak |
| Quality | 60 | Strong |
| Risk | 45 | Moderate |
Company facts
| Founded | 2017 |
| Employees | 40 |
| 52-week range | $3.35 – $17.94 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-11 | — | -0.7813 | — | $0.00 |
| 2026-08-19 | — | -0.8917 | — | $0.00 |
| 2026-05-07 | -0.99 | -0.8948 | $0.00 | $0.00 |
| 2026-03-23 | -0.81 | -0.8494 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish